Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04893083 · ClinicalTrials.gov registry record
A Non-interventional Study for the Collection of Biospecimens From Patients With Parkinson's Disease
A clinical trial, sponsored by Neuron23.
- Terminated
- Registry status
- 65
- Enrollment target
NCT04893083 is a clinical trial that was terminated before completion, run by Neuron23. The registered enrollment target is 65 participants.
The verdict
NCT04893083 was terminated before completion, sponsored by Neuron23.
- TERMINATED
- Registry status
- 65 participants
- Enrollment target
Study Summary
This study aims to collect, analyze and preserve biospecimens from patients with or without LRRK2-associated Parkinson's Disease for the purpose of discovering and developing new treatments and novel biomarkers.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2021-06-28 |
| Est. Completion | 2023-09-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04893083
The ClinicalTrials.gov registry entry for NCT04893083 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Neuron23, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04893083 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04893083 about?
NCT04893083 is a clinical study titled "A Non-interventional Study for the Collection of Biospecimens From Patients With Parkinson's Disease". This study aims to collect, analyze and preserve biospecimens from patients with or without LRRK2-associated Parkinson's Disease for the purpose of discovering and developing new treatments and novel biomarkers.
What is the current status of trial NCT04893083?
This trial is currently terminated. The enrollment target is 65 participants. The study started on 2021-06-28. Estimated completion is 2023-09-22.
Who is sponsoring clinical trial NCT04893083?
This trial is sponsored by Neuron23, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.